Photo Credit: Satyakam Banerjee/VCCircle

True North makes partial exit from drug research firm with strong gains

18 May, 2017

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.


Leave Your Comment
Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Joseph Rai 7 months ago
Private equity firm India Value Fund Advisors (IVFA), which raised a new fund last year and has been simultaneously looking to exit investments from its...
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Anuradha Verma 2 years ago
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the stock exchanges, listing at a...
Biocon to open IPO of R&D arm Syngene end of this month, fixes price band

Biocon to open IPO of R&D arm Syngene end of this month, fixes price band

Anuradha Verma 2 years ago
Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development subsidiary Syngene International Ltd at...
No Comments

True North makes partial exit from drug research firm with strong gains

Powered by WordPress.com VIP